Novartis
NVS
#58
Rank
ยฃ190.08 B
Marketcap
ยฃ99.06
Share price
-0.20%
Change (1 day)
28.84%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Revenue for Novartis (NVS)

Revenue in 2025 (TTM): ยฃ42.83 Billion

According to Novartis's latest financial reports the company's current revenue (TTM ) is ยฃ42.25 Billion. In 2024 the company made a revenue of ยฃ41.21 Billion an increase over the revenue in the year 2023 that were of ยฃ36.62 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Novartis from 2000 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ42.83 B3.92%
2024 ยฃ41.21 B12.54%
2023 ยฃ36.62 B-10.97%
2022 ยฃ41.13 B5.02%
2021 ยฃ39.17 B7.01%
2020 ยฃ36.60 B-1.38%
2019 ยฃ37.12 B-1.56%
2018 ยฃ37.70 B1.65%
2017 ยฃ37.09 B-7.41%
2016 ยฃ40.06 B17.83%
2015 ยฃ34.00 B-1.3%
2014 ยฃ34.44 B1.92%
2013 ยฃ33.80 B-5.09%
2012 ยฃ35.61 B-6.77%
2011 ยฃ38.20 B14.37%
2010 ยฃ33.40 B19.83%
2009 ยฃ27.87 B-4.07%
2008 ยฃ29.05 B48.91%
2007 ยฃ19.51 B9.2%
2006 ยฃ17.86 B-5.05%
2005 ยฃ18.81 B27.9%
2004 ยฃ14.71 B5.86%
2003 ยฃ13.89 B-4.43%
2002 ยฃ14.54 B8.34%
2001 ยฃ13.42 B-3.75%
2000 ยฃ13.94 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Merck
MRK
ยฃ48.14 B 13.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ47.06 B 11.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ69.07 B 63.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ35.62 B-15.69%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
ยฃ31.74 B-24.87%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
ยฃ12.57 B-70.24%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bristol-Myers Squibb
BMY
ยฃ36.00 B-14.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ32.86 B-22.23%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ43.57 B 3.11%๐Ÿ‡ฌ๐Ÿ‡ง UK